www.xinhuanet.com
XINHUA online
CHINA VIEW
VIEW CHINA
 Breaking News Urgent: Saddam Hussein trial resumes in Baghdad    Gunmen attack military camp in southern Thailand    Sri Lankan naval base attacked     UK troops withdraw from violent district in S Afghanistan    One killed, 12 injured in bus crash in HK    Two killed, 60 injured in subway train collision in Rome    
Home  
China  
World  
Business  
Technology  
Opinion  
Culture/Edu  
Sports  
Entertainment  
Life/Health  
Travel  
Weather  
RSS  
  About China
  Map
  History
  Constitution
  CPC & Other Parties
  State Organs
  Local Leadership
  White Papers
  Statistics
  Major Projects
  English Websites
  BizChina
- Conferences & Exhibitions
- Investment
- Bidding
- Enterprises
- Policy update
- Technological & Economic Development Zones
Online marketplace of Manufacturers & Wholesalers
   News Photos Voice People BizChina Feature About us   
Switzerland announces stockpiling of bird flu vaccine
www.chinaview.cn 2006-10-19 05:37:02

    GENEVA, Oct. 18 (Xinhua) -- Switzerland has ordered enough bird flu vaccine to protect its entire population in the event of a pandemic, the government announced on Wednesday.

    The government said this amounted to 8 million doses of a new pre-pandemic vaccine made by Anglo-American firm GlaxoSmithKline. The cost is expected to be 180 million Swiss francs (about 142 million U.S. dollars).

    Supply and stockpiling of the medication is expected to take place from January 2007, said a government statement.

    "If needed, it will therefore be possible to offer a first immunization to the whole of the (7.4 million) population," the statement said.

    "This vaccination will be voluntary and will only be administered once its effect against a pandemic virus has been proven," it added.

    Advanced development efforts to create an effective H5N1 influenza vaccine are currently based on a H5N1 virus isolated from a Vietnamese patient infected by a chicken in 2004.

    Since there is no pandemic among humans, this vaccine is referred to as a pre-pandemic H5N1 vaccine. The pre-pandemic vaccine helps prepare the human immune system against the threat of a human pandemic.

    Should a pandemic virus emerge that can be easily transmitted among humans, a vaccine based on that specific strain will have to be developed.

    The Swiss government has therefore concluded a further agreement with Glaxo for 7.5 million doses of a pandemic vaccine should the need arise.

    The immunization program, part of Switzerland's national bird flu plan, will be carried out by the authorities concerned and the cantons.

    Switzerland's bird flu action plan, finalized in August, proposes detailed guidelines, plans and responses in the event of an outbreak of the virus in the country.

    The central-European country has already built up a stock of the anti-viral drug Tamiflu to treat more than 2 million people and protect health workers.

    It has also continued to protect its borders from a possible outbreak of the virus. The latest measures include locking up poultry kept within one kilometer of major Swiss lakes and rivers.

    According to the latest Swiss government plan, 1.85 million people in the country could become infected with bird flu if the virus is able to pass from human to human.

    In that event, 46,000 Swiss people would be admitted to hospital and around 7,400 people would die. Such a pandemic would cost an estimated 2.3 billion Swiss francs (about 1.8 billion U.S. dollars). Enditem 

Editor: Mu Xuequan
  Related Story  
Copyright ©2003 Xinhua News Agency. All rights reserved.
Reproduction in whole or in part without permission is prohibited.